Back to Agenda
Inside the Investor’s Mind: How Today’s Biotech Investors Choose Where to Place Their Bets
Session Chair(s)
Katie Truong
SVP & Managing Director, DIA Americas and Global Head of Business Operations
DIA, United States
This session takes participants inside the investor’s mind in today’s complex funding environment. Investors and financial leaders will discuss how they evaluate pipelines, platforms, and partnerships, where they look for differentiated deal flow, how valuation frameworks are changing, and what ultimately convinces them to lean in—or pass.
Learning Objective : Explain how current biotech investors evaluate pipelines, platforms, and partnerships in today’s funding climate; Describe how valuation frameworks, risk appetite, and evidence expectations are evolving across stages and modalities; Identify what ultimately convinces investors to engage, lean in, or pass and how companies can position themselves accordingly.
Have an account?